Data from - Curated by EPG Health - Last updated 02 August 2018

Accrediting Body

Union of European Medical Specialists (via European Accreditation Council for CME)


1 credit



On completion of the activity, participants will:

  • understand the diagnostic and staging procedures as outlined in the 2015 ESMO CLL clinical practice guidelines including any updates from the 2011 version
  • appreciate the growing importance of identifying the genetic and IGHV status of patients and how this can help tailor treatment
  • understand the changing therapeutic landscape, the latest treatment recommendations including the amends made in the recent 2015 ESMO update, and current developments that may impact CLL management in future
  • recognise the importance of optimising patient treatment and understand how to manage adverse events to ensure patients get the most out of each therapy.

Category Value
Expiry date 31-Jul-20
Credit type Credit
Registration with provider required Yes
Certificate available Yes
Multi session Yes
Intended audience(s) Specialist
Assessment method(s) Multiple choice

Start CME


You will need to login, to leave a comment. is not monitored for collection of adverse event reports. Any adverse events should be reported to your national reporting agency and/or the manufacturer.

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Chronic Lymphocytic Leukaemia (CLL)

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

+ 1 more

CDK 4/6 inhibitors in metastatic breast cancer

CDK 4/6 inhibitors in metastatic breast cancer

The CDK 4/6 Inhibitors in Metastatic Breast Cancer Learning Zone provides insights and information for metastatic breast cancer (mBC) and CDK 4/6 signalling. This includes the burden and pathophysiology of the disease, the role of CDK 4/6 in cell proliferation and an overview of the CDK 4/6 inhibitors that have been approved for the management of mBC.

Cushing's Syndrome

Cushing's Syndrome

Cushing’s syndrome shares symptoms such as hypertension, glucose intolerance and obesity with other common conditions – how can you confidently diagnose this rare disorder?

+ 2 more

Load more

Related Content